Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Envoy Medical (NASDAQ: COCH) will report its third-quarter financial results on November 5, 2026, followed by a management conference call.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Envoy Medical (NASDAQ: COCH) will report its third-quarter financial results on November 5, 2026, followed by a management conference call.
The results cover the quarter ended September 30, 2026. The call will begin at 4:30 P.M. ET that day, with a replay available through November 19, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management Will Host a Conference Call at 4:30 P.M. ET on the Same Day
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it will report its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.
Third Quarter 2026 Financial Results Conference Call:
Date: Thursday, November 5, 2026
Time: 4:30 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: https://ir.envoymedical.com/news-events/ir-calendar
For interested individuals unable to join the conference call, a replay will be available through November 19, 2026, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11162715.
To be added to the Envoy Medical email distribution list, please email Envoy@kcsa.com with COCH in the subject line.
About Envoy Medical, Inc.
Envoy Medical (NASDAQ: COCH) is a hearing health and neuroprosthetics company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.
Investor Contact:
Phil Carlson
KCSA Strategic Communications
O: 212.896.1233
E: Envoy@kcsa.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321048